ArticleMolecules (Basel, Switzerland)2016
Bioactivities of a New Pyrrolidine Alkaloid from the Root Barks of Orixa japonica.
Article in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 46 citations in OpenAlex.
- Pyrrolidine-based hybrid compounds: design, synthesis, in vitro and in vivo pharmacological properties and molecular docking studies.Future medicinal chemistry · 2025Article
- Recent synthetic strategies for N-arylation of pyrrolidines: a potential template for biologically active molecules.Molecular diversity · 2025Review
- Naturally-occurring nematicides of plant origin: two decades of novel chemistries.Pest management science · 2025Review
- Article
- Current Status and Prospects of Pine Wilt Disease Management with Phytochemicals-A Review.Plants (Basel, Switzerland) · 2024Review
- Nematicidal Activity of Phytochemicals against the Root-Lesion NematodePlants (Basel, Switzerland) · 2024Article
- The Chemical Ecology of Plant Natural Products.Progress in the chemistry of organic natural products · 2024Review
- Development of trisubstituted thiophene-3-arboxamide selenide derivatives as novel EGFR kinase inhibitors with cytotoxic activity.RSC medicinal chemistry · 2023Article
- Insights from the Endophytic Fungi inMicroorganisms · 2023Article
- GC-MS Analysis of the Essential Oil fromMolecules (Basel, Switzerland) · 2023Article
- Therapeutic potential of pyrrole and pyrrolidine analogs: an update.Molecular diversity · 2022Review
- In Silico Approaches to Identify Polyphenol Compounds as α-Glucosidase and α-Amylase Inhibitors against Type-II Diabetes.Biomolecules · 2021Review
- Pyrrolidine in Drug Discovery: A Versatile Scaffold for Novel Biologically Active Compounds.Topics in current chemistry (Cham) · 2021Review
- Characterization of the complete chloroplast genome of the medicinal plantMitochondrial DNA. Part B, Resources · 2021Article
- Plant Natural Products for the Control ofMolecules (Basel, Switzerland) · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A new pyrrolidine alkaloid named (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.